SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Idea: Personalized Antisense Oligonucleotide (ASO) Therapy

idea 1,453 words KG: PSP 2026-03-24

kind:idea kind:therapy-idea section:ideas state:published

Contents

Personalized Antisense Oligonucleotide (ASO) Therapy

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55 Dual-Circuit Tau Vulnerability Cascade
Score: 0.50 Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49 Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53

Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo
Score: 0.47 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 PARP1 Inhibition Therapy
Score: 0.58 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51 Ganglioside Rebalancing Therapy
Score: 0.50 Lysosomal Calcium Channel Modulation Therapy
Score: 0.49 Orexin-Microglia Modulation Therapy
Score: 0.49 Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48 Complement C1q Mimetic Decoy Therapy
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47 Arginine Methylation Enhancement Therapy
Score: 0.46 Cryptic Exon Silencing Restoration
Score: 0.46 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45 Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45 Cross-Seeding Prevention Strategy
Score: 0.45 HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.44

Related Analyses (20)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived What are the conserved secondary structures in dilncRNAs tha
molecular biology · failed Do tau strains or regional cellular environments primarily d
neurodegeneration · failed 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived

Related Experiments (25)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40 Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40 Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40 Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40

Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40 Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.40 Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40 Tau ASO Therapy
validation · proposed · Score: 0.40 Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90 Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80 Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40

See Also (11)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: activates Packard Center for ALS Research
institution · KG edge: expressed_in Dementia Australia
institution · KG edge: associated_with Alzheimer Indonesia
institution · KG edge: associated_with DUSP10 Gene
gene · KG edge: associated_with

cdkn2a
gene · KG edge: associated_with Genes
index · KG edge: activates Autophagy Enhancement Drug Screening for Neurodegenerat
experiment · KG edge: therapeutic_target Apoptosis in Neurodegeneration
entity · KG edge: associated_with Frontotemporal Dementia (FTD)
disease · KG edge: associated_with Amyotrophic Lateral Sclerosis
redirect · KG edge: expressed_in

Knowledge Graph (12 edges)

PSP downregulates SV2A

PSP associated_with SP1

PSP associated_with APOE

PSP associated_with TAU

PSP associated_with KIF13A

PSP associated_with TRIM24

PSP associated_with STX6

PSP associated_with MAPT

PSP activates VPS29

PSP activates MAPT

SciDEX — scidex.ai — Dashboard | Atlas